The turnover of Shanghai, Shenzhen and Beijing exceeded 1.5 trillion, exceeding 430 billion compared with yesterday.World Bank: Kenya's growth forecast for 2024 is lowered to 4.7% due to financial challenges.The Syrian opposition said it would hunt down and punish "those who committed crimes against the Syrian people". Syrian opposition leader Giulani announced on the morning of 10th local time that it would hunt down and punish "those who committed crimes against the Syrian people". Giulani said in a statement that he would "resolutely liquidate the criminals, murderers, military and security officials involved in torturing the Syrian people" and "pursue war criminals and pursue them to the countries where they fled until they are justly punished". The statement also said that the first "list of ringleaders who tortured the Syrian people" will be released soon, and those who provide information about senior military and security officials involved in the crime will be rewarded. (CCTV News)
Shisi Pharmaceutical Group: Dilalos dispersible tablets (125mg) have obtained the approval of pharmaceutical production registration. Shisi Pharmaceutical Group announced on the Hong Kong Stock Exchange on December 10th that it has obtained the approval of pharmaceutical production registration of Dilalos dispersible tablets (125mg) in National Medical Products Administration, China, which belongs to the fourth category of chemicals and is deemed to have passed the consistency evaluation. Deslorax dispersible tablets are mainly used to treat chronic iron overload caused by frequent blood transfusion in patients with β -thalassemia over two years old, and chronic iron overload in patients with transfusion-independent thalassemia syndrome over 10 years old.Afternoon comment: The Shanghai Composite Index rose more than 1% in half a day, and consumer concept stocks broke out collectively. The index was active in early trading. The Shanghai Composite Index rose more than 1% in half a day, and the Shanghai Composite Index rose more than 2%. In terms of sectors, robot concept stocks continued to break out, and the concept of PEEK materials led the rise. Both China Research Institute and Xinyi New Materials had a daily limit of 20cm, while Zhongxin Fluorescent Materials and Walter shares touched the daily limit; The large consumer sector collectively rose, with dairy stocks leading the gains, and Panda Dairy, Western Animal Husbandry and Li Ziyuan were trading daily; AI concept stocks fluctuated higher, and it is worth buying 20cm daily limit, Hanwang Technology, Xinhua Media and other daily limit; Insurance stocks strengthened, and Tianli Technology, Astar, Focus Technology and other daily limit. Overall, individual stocks showed a general upward trend, with more than 4,600 stocks rising. On the disk, all sectors in the two cities generally rose, with PEEK materials, film and television theaters and dairy sectors among the top gainers.The researcher of Everbright Bank commented on China's import and export data in November: the export growth rate is stronger than seasonality, and foreign trade exports are expected to grow steadily in the next few months. Zhou Maohua, a macro researcher in the financial market department of Everbright Bank, told Wall Street that the export growth rate in November was stronger than seasonality, the import decline exceeded expectations (weaker than seasonality), the trade surplus expanded, and foreign trade contributed more to the economy in the fourth quarter. Due to the resilience of overseas demand, overseas foreign trade importers rushed to avoid tariffs and hoarded goods in advance, and the effects of policies such as stabilizing foreign trade appeared, driving export growth to exceed expectations; The decline in imports in November exceeded expectations, mainly due to the weak recovery of domestic demand, the cautious decision of enterprises to expand and increase import inventory, and the low prices of international energy and other commodities that depressed the overall import cost.
The investment of Shanghai private equity venture capital industry in the first three quarters was 45.947 billion yuan, a year-on-year decrease of 50%. On December 10th, at the 17th Bund Finance Shanghai International Equity Investment Forum, the development report of Shanghai private equity venture capital industry in 2024 was officially released. According to the report, in the first three quarters of 2024, there were 327 investments in Shanghai private equity venture capital industry, a year-on-year decrease of 47%; The total investment was 45.947 billion yuan, a year-on-year decrease of 50%. All rounds of financing activities have decreased, especially the A+ round, B round, D round and private placement round. The report also shows that in the first three quarters of 2024, the total amount of investment subscribed by Shanghai LP was about 67 billion yuan, a year-on-year increase of 15.61%; A total of 301 LPs were invested, a year-on-year decrease of 50.25%.Australia's 3-year bond yields fell by 3 basis points after the RBA commented on inflation.Dotinolole, a new drug used by Weicai to treat gout, was approved for marketing in China. On December 10th, Weicai China announced that its new urate reuptake inhibitor Dotinolole tablets (trade name: Youlesi) had been approved by National Medical Products Administration (NMPA) in China, and its indication was gout with hyperuricemia.